Lara's Bakery 3 Chocoflan recall — FDA F-0791-2024
Contains statement declares gluten but not major allergen of wheat. Potential for unintended allergen presence (Sesame Seed, Coconut, Soy, Wheat, Milk and Eggs).
Complete FDA and NHTSA recall records dated in 2024, organized for browsing by month, category and recalling company.
Select a month to review the recall records reported during that period.
Records are ordered by the best available source date.
Contains statement declares gluten but not major allergen of wheat. Potential for unintended allergen presence (Sesame Seed, Coconut, Soy, Wheat, Milk and Eggs).
Contains statement declares gluten flour but not major allergen of wheat. Potential for unintended allergen presence (Sesame Seed, Coconut, Soy, Wheat, Milk and Eggs).
The underlying ingredient, shredded lettuce, was recalled by the supplier Fresh Express due to potential contamination with Listeria monocytogenes.
The underlying ingredient, shredded lettuce, was recalled by the supplier Fresh Express due to potential contamination with Listeria monocytogenes.
The underlying ingredient, shredded lettuce, was recalled by the supplier Fresh Express due to potential contamination with Listeria monocytogenes.
The underlying ingredient, shredded lettuce, was recalled by the supplier Fresh Express due to potential contamination with Listeria monocytogenes.
Undeclared allergens - sesame. Potential for unintended allergen presence (Sesame, Coconut, Soy, Wheat, Milk and Eggs).
Undeclared milk
The underlying ingredient, shredded lettuce, was recalled by the supplier Fresh Express due to potential contamination with Listeria monocytogenes.
Undeclared allergens - sesame seed, coconut, soy, milk. Potential for unintended allergen presence (Sesame, Coconut, Soy, Wheat, Milk and Eggs).
Failed Excipient Specifications: OOS for assay of Isopropyl Alcohol
Lack of Sterility Assurance: Aseptic process simulation failure.
CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
Superpotent drug: Assay results were slightly above specification at the time zero point.
CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
This archive groups records by their reported or recall date. It does not imply that every recall was initiated, announced and resolved during the same calendar year. Open the individual record for the exact dates and source details supplied by FDA or NHTSA.